These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10938694)

  • 1. [New blood transfusion partners in France].
    Lassale B; Fuentes AM; Legrand D; Sambuc R
    Presse Med; 2000 Jul 8-15; 29(24):1357-60. PubMed ID: 10938694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What is the use of hemovigilance?].
    Quaranta JF; Canivet N
    Transfus Clin Biol; 1998 Dec; 5(6):415-21. PubMed ID: 9894333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supply and safety through one agency--the Singapore experience.
    Teo D; Lim PS
    Dev Biol (Basel); 2007; 127():153-8. PubMed ID: 17486888
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood transfusion surveillance: organization and results].
    Rebibo D; Morel P; Hauser L; Hervé P
    Rev Prat; 2001 Jun; 51(12):1332-6. PubMed ID: 11503507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inspection of transfusion sites by the French Blood Establishment].
    Chevrolle F; Hadzlik E; Suchel PL
    Transfus Clin Biol; 2001 Dec; 8(6):485-9. PubMed ID: 11802612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why is it necessary to review the December 15th 2003 circular relative to the transfusion act?].
    Lassale B; Besse-Moreau M; Aullen JP
    Transfus Clin Biol; 2014 Nov; 21(4-5):223-6. PubMed ID: 25267206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French haemovigilance system.
    Noel L; Debeir J; Cosson A
    Vox Sang; 1998; 74 Suppl 2():441-5. PubMed ID: 9704479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is haemovigilance improving transfusion practice?--The european experience.
    Strengers PF
    Dev Biol (Basel); 2007; 127():215-24. PubMed ID: 17486895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serious events: from statutory requirements to the implementation].
    Aullen JP; Lassale B; Verdot JJ
    Transfus Clin Biol; 2008 Nov; 15(5):217-22. PubMed ID: 18938098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood transfusion: the challenges for tomorrow?].
    Folléa G; Garraud O; Tiberghien P
    Presse Med; 2015 Feb; 44(2):227-32. PubMed ID: 25578549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

  • 13. [Position of French transfusion operator in the regulation of territorial care in a changing context].
    Thibert JB
    Transfus Clin Biol; 2015; 22(5-6):326-37. PubMed ID: 26603288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proclamation of the Blood Working Group "Recommendation for appointment and responsibilities of transfusion coordinators, transfusion personnel, transfusion commissions and professional groups for hemotherapy": clarification and implementation].
    Hanfland P; Götz E; Kretschmer V
    Infusionsther Transfusionsmed; 1995 Dec; 22(6):379-83. PubMed ID: 8589599
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood transfusion and supply chain management safety].
    Quaranta JF; Caldani C; Cabaud JJ; Chavarin P; Rochette-Eribon S
    Presse Med; 2015 Feb; 44(2):214-20. PubMed ID: 25578550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What are the rules and regulations for blood product transfusion in France?].
    Pélissier E; Bierling P
    Rev Prat; 2009 Jan; 59(1):90-2. PubMed ID: 19253890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality assurance in transfusion medicine: organization of a quality assurance system exemplified by the Heidelberg University Blood Bank].
    Stahl D; Kluge A; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1996; 33():247-56. PubMed ID: 8974702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on regulatory framework and certification process].
    Legrand D
    Transfus Clin Biol; 2008 Nov; 15(5):193-6. PubMed ID: 18930686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Judicial liability and blood transfusion--equity, opportunity?].
    Hermitte MA
    Transfus Clin Biol; 1997; 4(3):321-8. PubMed ID: 9264790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.